Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Lowered to $185 at Cantor Fitzgerald

February 12, 2019 11:54 AM
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles